---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-075440"
form_type: "8-K"
ticker: "RNAZ"
cik: "0001829635"
company_name: "Transcode Therapeutics, Inc."
filed_at: "2026-06-18T12:00:37+00:00"
generated_at: "2026-06-18T12:05:50.015996+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# TransCode Therapeutics posts corporate presentation; no specific details disclosed

## Summary
- Presentation titled 'Three Platforms, One Mission: Transforming Advanced Cancer Care' posted on June 18, 2026.
- Presentation may be used with investors, analysts, collaborators, and other third parties.
- No financial or operational updates were included in the filing or exhibit.

## SEC filing metadata
- accession: 0001104659-26-075440
- form_type: 8-K
- ticker: RNAZ
- cik: 0001829635
- company_name: Transcode Therapeutics, Inc.
- filed_at: 2026-06-18T12:00:37+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829635/000110465926075440/0001104659-26-075440-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829635/000110465926075440/tm2618153d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-075440
- JSON: https://secwatch.observer/filing/0001104659-26-075440.json
- Plain text: https://secwatch.observer/filing/0001104659-26-075440.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.